Advanced Oncotherapy to present at the Innovators & Investors Forum 2016

Advanced Oncotherapy to present at the Innovators & Investors Forum 2016. (From Stockmarket Wire)   Nicolas Serandour, CFO of proton therapy systems developer Advanced Oncotherapy (AVO), [AVO] is to present at the Innovators & Investors Forum 2016 in London on Tuesday 2nd February 2016.  The Innovators & Investors Forum is organised in partnership with Cenkos […]

Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy

Malcolm Stacey’s share tip of the year No 1 – buy Advanced Oncotherapy By Malcolm Stacey | Saturday 26 December 2015 Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I […]

Advanced Oncotherapy – Additional Director Dealing

Advanced Oncotherapy (AVO) announces that Michael Sinclair, Executive Chairman of the Company, on 18 December 2015 purchased 500,000 ordinary shares of 1 penny each in the Company at 6.25 pence per Ordinary Share. The Company also announces that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, […]

Advanced Oncotherapy – Additional Director Dealing

Advanced Oncotherapy (AVO) announces that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, yesterday purchased 1,000,000 ordinary shares of 1 penny each in the Company at 5.75 pence per Ordinary Share. Following this transaction, Michael Bradfield now holds 123,768,510 Ordinary Shares representing 8.73% of the issued […]

Advanced Oncotherapy – Director Dealing

Advanced Oncotherapy (AVO) announces that Fairford Capital Ltd, of which Michael Bradfield, a Non-Executive Director of the Company, is the sole beneficial owner, yesterday purchased 750,000 ordinary shares of 1 penny each in the Company at 5.5 pence per Ordinary Share. Following this transaction, Michael Bradfield now holds 122,768,510 Ordinary Shares representing 8.66% of the […]

Advanced Oncotherapy – Scientists put final pieces in place for seeing cancer with protons

Scientists are currently putting together a unique medical imaging platform that could improve treatment for millions of cancer sufferers by making proton therapy a viable option. Members of the multi-national research team behind the Proton Radiotherapy Verification and Dosimetry  Applications (PRaVDA) project, led by the University of Lincoln, UK, are now building the instrument that will produce […]

Bid for cutting-edge cancer treatment centre submitted

Bid for cutting-edge cancer treatment centre submitted. A planning application has now been submitted for a state-of-the-art cancer centre in Northumberland – likely to be the first to become operational in England. An example of how the treatment rooms will look at the new centre. As reported earlier this year, the Proton Beam Therapy treatment centre, […]